Official websites use .gov
A
.gov
website belongs to an official government organization in the
United States.
Secure .gov websites use HTTPS
A
lock
(
) or
https://
means you’ve safely connected to the .gov website. Share sensitive
information only on official, secure websites.
PubMed ID:
32936969
Public Release Type:
Journal
Publication Year: 2021
Affiliation: Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.; Hepatology Division, Baylor Scott and White Medical Center, Dallas, TX.; Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.; UNC Liver Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Epidemiology and Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.; Liver Diseases Branch, NIDDK, NIH, Bethesda, MD.; Department of Medicine, Division of Gastroenterology and Hepatology, University of California San Francisco, San Francisco, CA.; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.; Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond, VA.; Division of Gastrointestinal and Liver Diseases, Keck Medicine of University of Southern California, Los Angeles, CA.; Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, ON, Canada.; Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO.; Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolois, MN.; Toronto Centre for Liver Disease, University of Toronto, Toronto, ON, Canada.
DOI:
https://doi.org/10.1002/hep.31554
Authors:
Lok Anna S., Perrillo Robert, Lalama Christina M., Fried Michael W., Belle Steven H., Ghany Marc G., Khalili Mandana, Fontana Robert J., Sterling Richard K., Terrault Norah, Feld Jordan J., Di Bisceglie Adrian M., Lau Daryl T.Y., Hassan Mohamed, Janssen Harry L.A.
Request IDs:
22748
,
22774
Studies:
Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults with Chronic Hepatitis B
Outcomes of persons with chronic hepatitis B virus (HBV) infection in the era of antiviral therapy (AVT) are not well characterized. We determined the incidence and factors associated with clinical outcomes in a multiethnic, North American cohort of adults with chronic HBV infection, who were not on AVT at enrollment.
